What is Streptococcus anginosus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Streptococcus anginosus?

Streptococcus anginosus is a member of the viridans group streptococci (VGS) that is uniquely characterized by its tendency to form abscesses and cause hematogenously disseminated infections, distinguishing it from other α-hemolytic streptococcal species. 1

Microbiological Classification

  • S. anginosus belongs to the S. anginosus group (also historically called the S. milleri group), which includes three species: S. anginosus, S. intermedius, and S. constellatus 1, 2

  • This group is part of the normal human flora and commonly colonizes the gastrointestinal tract, oral cavity, and genitourinary tract 3, 4

  • The organism is typically α-hemolytic on blood agar, though this taxonomy has caused some historical confusion 1

Unique Clinical Characteristics: The Abscess-Former

The defining feature that sets S. anginosus apart from other viridans streptococci is its propensity to form deep-seated abscesses and cause metastatic infections. 1, 2

Sites of Abscess Formation:

  • Brain abscesses 2, 5, 6
  • Myocardial abscesses 1, 2
  • Visceral abscesses (liver, spleen) 1, 2, 4, 5
  • Muscle abscesses (pyomyositis) 7
  • Septic arthritis 1, 2
  • Vertebral osteomyelitis 1, 2

Antimicrobial Susceptibility

  • The S. anginosus group is usually sensitive to penicillin, but some strains may exhibit variable penicillin resistance 1, 2

  • This variable resistance pattern is clinically important and distinguishes it from other α-hemolytic streptococci that are more predictably penicillin-susceptible 1

  • Treatment typically involves β-lactams (penicillin G or cephalosporins), often combined with surgical drainage 5

Critical Clinical Associations

Infective Endocarditis

  • S. anginosus causes infective endocarditis as part of the viridans streptococci group 2, 3

  • When S. anginosus endocarditis is diagnosed, a systematic search for metastatic abscesses should be conducted by imaging the brain, liver, spleen, and myocardium 2

  • The duration of antimicrobial treatment may need to be longer than for other α-hemolytic streptococci due to its abscess-forming tendency 2

Colorectal Malignancy

  • S. anginosus bacteremia has an association with colorectal cancer, similar to but less well-established than the association with Streptococcus gallolyticus (bovis) 4

  • Clinicians should consider screening for colorectal cancer in patients presenting with S. anginosus bacteremia, particularly when accompanied by liver abscesses 4

Important Clinical Pitfalls

Don't Dismiss as a Contaminant

  • Even a single positive blood culture growing S. anginosus should prompt careful evaluation for a pyogenic focus of infection 7

  • Because it is part of normal flora, it may be mistakenly dismissed as a contaminant when labeled generically as "viridans streptococci" 7

Disseminated Infection Recognition

  • S. anginosus can cause highly disseminated pyogenic infections affecting multiple organ systems simultaneously 5

  • Concomitant brain-liver involvement occurs in 50% of disseminated cases, brain-lung in 42%, and brain-spleen in 8% 5

  • Underlying conditions such as dental infections, malignancy, and gastrointestinal disease are present in 42% of cases 5

Surgical Intervention is Often Necessary

  • Surgical drainage is required in approximately 67% of S. anginosus infections to achieve full clinical recovery 5

  • Antimicrobial therapy alone is often insufficient due to the abscess-forming nature of this organism 5, 6

  • Delayed diagnosis and treatment can be fatal, particularly in central nervous system infections 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Streptococcus intermedius and Endocarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An unusual case of Streptococcus anginosus group pyomyositis diagnosed using direct 16S ribosomal DNA sequencing.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.